Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
33.3%
% of IBRN's 60 holdings also in SBIO
16.5%
% of SBIO's 90 holdings also in IBRN
Overlap by Weight
Sector Drift (IBRN minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBRN |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
ALKERMES PLC | 4.1% | 4.5% | 4.1% |
 |
PTC THERAPEUTICS INC | 4.4% | 3.6% | 3.6% |
|
ACADIA PHARMACEUTICALS INC | 4.1% | 2.4% | 2.4% |
|
DENALI THERAPEUTICS INC. | 3.7% | 1.9% | 1.9% |
|
EDGEWISE THERAPEUTICS, INC. | 3.3% | 1.9% | 1.9% |
Position Highlights (Non-Overlapping Exposures)
IBRN Overweight Relative to SBIO
|
CATALYST PHARMACEUTICAL PART | 4.7% |
|
INTRA-CELLULAR THERAPIES INC | 4.2% |
|
NEUROCRINE BIOSCIENCES INC | 4.2% |
 |
ARGENX SE ADR | 4.2% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | 3.9% |
|
BIOGEN IDEC INC | 3.9% |
|
SCHOLAR ROCK HOLDING CORP. | 3.9% |
|
SUPERNUS PHARMACEUTICALS INC | 3.7% |
|
INTEGRA LIFESCIENCES HOLDING | 3.1% |
|
SAREPTA THERAPEUTICS INC | 2.9% |
IBRN Underweight Relative to SBIO
|
AXSOME THERAPEUTICS, INC. | -4.5% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -3.3% |
|
AVIDITY BIOSCIENCES INC | -3.2% |
|
RHYTHM PHARMACEUTICALS, INC. | -3.0% |
|
AKERO THERAPEUTICS, INC. | -2.9% |
|
CRINETICS PHARMACEUTICALS INC | -2.7% |
 |
MERUS N.V. | -2.7% |
|
PROTAGONIST THERAPEUTICS, INC. | -2.6% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -2.2% |
|
AMICUS THERAPEUTICS INC | -2.2% |